Contact Us

General Inquiries
Medical Inquiries

Get in touch

To contact our corporate communications, media relations, investor relations, talent acquisition or business development groups, or to ask a general question about the company, please fill out the form below.

Read our Privacy Notice to understand how we protect your privacy and how we may collect, use and share information.

All fields required unless otherwise noted.*

Area(s) of interest*

Business Development

Career/Candidate Support

Corporate Communications

Investor Relations

Media Relations

First Name*

Last Name*

Title (Optional)

Company/Institution (Optional)

Email Address*

Telephone (Optional)

Preferred Contact Method:*

Telephone

Address (Optional)

Address 2 (Optional)

City (Optional)

State/Province/Region (Optional)

Zip Code (Optional)

Country*

Message*

An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as Social Security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to [email protected].

Careers

Browse available jobs and send us an application.

Investors and Media

Get up to date on news, events, stock and financial information.

Medical inquiries

Healthcare professionals, patients or caregivers may request specific product information, report an adverse event or report a product complaint for a Regeneron product to our Global Medical Information Department. Please call 1-844-REGN-MID (1-844-734-6643) for further information.

To report an adverse event or product complaint for a Regeneron product outside of the United States please refer to the country specific Global Medical Information contact list.

With our commitment to patient safety, if you are reporting an adverse event or product complaint, please report as much relevant information as possible which may include product indication, lot number and return availability.